Strata Critical Medical Inc (SRTA) Price Prediction & ForecastSRTAStrata Critical Medical Inc

Alphio's SRTA stock price prediction model matches the current Strata Critical Medical Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $5.91 (-1.06%). The 1-week path is $5.78 (-3.14%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Strata Critical Medical Inc (SRTA) is a good buy right now due to its recent strong performance and positive outlook. The current price is $5.97, significantly lower than the analyst price targets of $8 and $11.50, indicating a potential upside of 33.5% to 93.5%. The company reported a 15.1% sequential increase in clinical revenue for Q2 2026, reaching $24.3 million, and raised its revenue guidance for 2026 to between $285 million and $295 million. However, the main risk is the negative net income reported for Q2 2026, amounting to -$10.52 million, which could affect investor sentiment.

Strata Critical Medical Inc (SRTA) last closed at $5.97, losing -3.24%. These facts feed the 1-day and 1-week SRTA price prediction above.